As malignant tumours develop, they interact intimately with their microenvironment and can activate autophagy 1 , a catabolic process which provides nutrients during starvation. How tumours regulate autophagy in vivo and whether autophagy affects tumour growth is controversial 2 . Here we demonstrate, using a well characterized Drosophila melanogaster malignant tumour model 3, 4 , that noncell-autonomous autophagy is induced both in the tumour microenvironment and systemically in distant tissues. Tumour growth can be pharmacologically restrained using autophagy inhibitors, and early-stage tumour growth and invasion are genetically dependent on autophagy within the local tumour microenvironment. Induction of autophagy is mediated by Drosophila tumour necrosis factor and interleukin-6-like signalling from metabolically stressed tumour cells, whereas tumour growth depends on active amino acid transport. We show that dormant growth-impaired tumours from autophagy-deficient animals reactivate tumorous growth when transplanted into autophagy-proficient hosts. We conclude that transformed cells engage surrounding normal cells as active and essential microenvironmental contributors to early tumour growth through nutrient-generating autophagy.
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To assess autophagy during Drosophila tumour growth, we generated green fluorescent protein (GFP)-labelled malignant Ras V12 scrib −/− eye imaginal disc (EAD) tumours in animals carrying the autophagosome marker Atg8a tagged with mCherry (ChAtg8a) under the control of its endogenous promoter 5, 6 . These tumours grow and invade the central nervous system, eventually killing the host 3, 4, 7 . In contrast to Ras ChAtg8a structures were readily assigned to autophagic structures by correlative light and electron microscopy (Extended Data Fig. 1c ) and were not observed in cells deficient in the essential autophagy gene atg13, and lysosomal processing of ChAtg8a increased in the presence of tumour cells ( Fig. 1c, d ; for gel source data, see Supplementary −/− cells (c). Insets (white outline) are shown enlarged with clones outlined in yellow. n = 24 (Ras V12 ctrl; ctrl refers to wildtype scrib chromosome), n = 20 (Ras V12 scrib −/− ) and n = 5 (Ras V12 scrib −/− //atg13 −/− ) discs from three independent experiments. d, Western blot analysis and quantification of ChAtg8a processing in EAD, representative of three independent experiments. e, ChAtg8a puncta in various tissues from feeding mid L3 larvae carrying Ras V12 clones. f, g, Ras V12 scrib −/− tumours in wild-type (f) and atg13-deficient animals (g). Representative confocal images of n = 11 (Ras V12 ctrl), n = 7 (Ras V12 scrib −/− ) and n = 4 (Ras V12 atg13 −/− scrib −/− //atg13 −/− ) animals from three independent experiments. h, Epifluorescent images of cephalic complex and VNC and tumour volume quantification of Ras V12 scrib −/− tumours at day 10 fed with chloroquine. n = 22 (untreated), n = 18 (Chloroquine). Data are mean ± s.e.m. from three independent pooled experiments (d, h). *P = 0.0266 from one-sample t-test (d); ***P = 0.0003 from unpaired two-tailed t-test (h). Scale bars, 50 μm (a-c) or 25 μm (e-g). For gel source images, see Supplementary Data.
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Information). Together, these data demonstrate that the presence of ChAtg8a puncta reflects autophagy activity in this system.
As adult Drosophila tumours have recently been found to induce a cachexia-like response in the animal 8, 9 , we assessed whether peripheral organs responded to eye-specific tumours in larvae. Upregulation of autophagy was observed in the muscle, fat body and midgut of Ras V12 scrib −/− but not Ras V12 tumour-bearing larvae and was lost altogether in atg13-deficient animals ( Fig. 1 e-g and Extended Data Fig. 2a) . Taken together, these data show that malignant Ras V12 scrib −/− , but not benign Ras V12 tumours lead to local and systemic noncell-autonomous autophagy (NAA).
Oral administration of the autophagy flux inhibitor chloroquine 10 led to a significant reduction in tumour growth and invasion ( Fig. 1h and Extended Data Fig. 2b ). Therefore, we investigated whether NAA in the microenvironment, distal organs or both may contribute to tumour growth. We generated recombinant chromosomes that allowed autophagy to be ablated through the induction of atg13 or atg14 deficiency in specific compartments during tumour growth (Extended Data Figs 3, 4) . Ras V12 scrib −/− tumours were generated with the simultaneous prevention of autophagy: (i) within the tumour only; (ii) in the surrounding cell population only; (iii) in both cell populations within the tumour-bearing organ; or (iv) in the entire animal.
Ras V12 scrib −/− tumours overgrew, with most invading into the ventral nerve cord (VNC) by day 8 (refs 3, 4, 7) (Fig. 2a, f and Extended Data Fig. 5a ). Consistent with previous work, we found that preventing autophagy within the tumour caused a moderate, albeit significant, reduction in tumour volume 11, 12 , but did not reduce invasion (Fig. 2b, f and Extended Data Fig. 5a ). By contrast, ablation of autophagy in cells surrounding Ras V12 scrib −/− clones strongly reduced tumour growth and invasion (Fig. 2c, f and Extended Data Fig. 5a ). Removal of autophagy in both cell populations through the creation of a mutant animal with complete loss of function in atg13 reduced tumour volume and invasiveness even further (Fig. 2d, f and Extended Data Fig. 5a ). In both contexts, tumour growth was rescued by complementation with a genomic atg13 construct (Fig. 2e, f and Extended Data Fig. 5b-f) . Each of these manipulations reduced the elevated cellcycle entry and progression displayed by tumour cells (Extended Data Fig. 6a-p) , with no marked increase in tumour apoptosis (Extended Data Fig. 6q-u) . Finally, we induced defective autophagy specifically in the tumour-bearing organ through mitotic recombination between the atg14 and atg13, scrib-carrying chromosome arms. Notably, tumour growth was reduced by a similar extent in this organ-specific mutant as in fully mutant atg13 animals, suggesting that the role autophagy plays in support of tumour growth is local (Fig. 2g-j) . To test this, we rescued atg13 expression specifically in eye discs 13 (ey3.5-atg13) and found that this restored autophagic activity and significantly rescued tumour growth in tumour-bearing atg13 mutant animals ( Fig. 2k and Extended Data Fig. 5g, h ). Values depict mean ± s.e.m. of three independent pooled experiments (f, j, k). NS, not significant, * P ≤ 0.05, * * P ≤ 0.01, * * * P < 0.0001 from one-way ANOVA with Dunnett's correction (f, j). * * P = 0.0011 from unpaired two-tailed t-test (k). ) animals or when JNK activity was blocked in the tumour (Fig. 3a-d and Extended Data Fig. 7b, k) , indicating that autophagy requires tumour-specific TNF/JNK signalling. Notably, systemic autophagy activation remained when JNK signalling was inhibited, suggesting that local and systemic control of autophagy are achieved by different mechanisms (Extended Data Fig. 7a 15, 20 . These tumours phenocopied Ras Fig. 7f, l) . The data suggest that the transcriptional target(s) that are required for NAA respond both to Yki/Sd and to Fos. Targets of Yki/Sd and Fos include the insulin-binding antagonist ImpL2, a mediator of organ wasting 8, 9 , and the IL-6-like inflammatory cytokines unpaired 1, unpaired 2 and unpaired 3 (ref. 19) . Although ImpL2 was neither necessary nor sufficient for the induction of NAA, the overexpression of either upd1 or upd3 with Ras V12 induced NAA, suggesting that these cytokines can mediate NAA ( Fig. 3g and Extended Data Fig. 7g -i, l, m).
To investigate how cytokine signalling may regulate NAA, we inactivated downstream JAK-STAT signalling in either tumours or the microenvironment specifically. We observed a robust NAA response in discs in which microenvironmental signalling was disrupted, but this was absent when signalling was inactivated in the tumour ( 
and rely on co-transcriptional changes in Fos-, Yki/Sd-and STATmediated mitogenic signalling.
The direct inducer of NAA in this context has still to be defined, but it may not be a single factor. Efforts to scavenge ROS by pharmaceutical or genetic means failed to reverse Ras V12 scrib −/− induced NAA, although scavenger efficacy could not be confirmed. Nevertheless, these data suggest that highly proliferative Ras V12 scrib −/− Drosophila tumours are metabolically stressed, produce high levels of ROS and potentially rely on increased import of nutrients-as in humans. Indeed, we observed an increase in the import of the fluorescently labelled glucose analogue (2-NBDG) in Ras V12 scrib −/− tumour cells (Extended Data Fig. 8k, l) Microenvironmental autophagy has been proposed to provide recycled nutrients, including amino acids, locally in order to support tumour growth 22 . If this is the case, then tumour growth should be hypersensitive to reduced amino acid import. To test this, we silenced the cationic and neutral amino acid transporter slimfast (encoded by slif), the loss of which has previously been shown to have minimal effect on proliferation of wild-type cells 23 . Silencing of slif markedly reduced growth of Ras V12 dlg1
RNAi tumours, indicating that the metabolic demand of tumour cells to sustain growth and proliferation is met, in part, by the increased import of amino acids ( Fig. 4a and Extended Data Fig. 9a ).
To investigate whether the requirement of autophagy for tumour growth is permanent and reliant on local factors, we performed allograft experiments 24 . Ras V12 scrib −/− allografts grew into large tumours, with a concomitant increase in control host ChAtg8a processing (Extended Data Fig. 9b, c) . Tumour growth could be pharmacologically restricted by administration of autophagy inhibitors; notably, tumours also grew more poorly in atg14
EY14568 hypomorphic hosts than in control hosts ( Fig. 4b and Extended Data Fig. 9d, e) . This suggests that the autophagy capacity of the host, and not tumour location or original tumour environment, determines growth. To investigate whether the lack of tumour growth in autophagy-deficient animals is reversible, we transplanted poorly growing Ras 
//atg13
−/− tumours into control or atg14 Δ5.2 /atg14 EY14568 hosts. Strikingly, this autophagy-deficient tumour tissue, which grew very poorly in atg13 mutant larvae (Fig. 2d) , was capable of regrowth and formed large tumours when transplanted into a control host (Fig. 4c) 
/atg14
EY14568 or atg8 hosts remained smaller ( Fig. 4c and Extended Data Fig. 9f) . Thus, autophagy-deficient tumours are dormant but can resume growth in an autophagy-proficient ectopic environment.
Malignant tumour growth induces autophagy, both in the microenvironment and distal tissues. Locally, normal epithelial cells are engaged as an active part of the microenvironment, supporting tumour proliferation by autophagy. Systemically, autophagy in distant organs may support the growth of allografted tumour tissue. Most previous studies have focused on the cell-autonomous role of autophagy in Ras-driven malignancies 2, 11, 25 . In line with these studies, we find that cell-autonomous autophagy supports tumour growth, although our experimental model shows that the non-cell-autonomous effects of autophagy are much more striking. Our studies are consistent with a model in which early tumours concomitantly upregulate the import of nutrients and engage the microenvironment to recycle nutrients to support their own growth through autophagy (Fig. 4d) . Given the conserved pathways studied, similar tumour-microenvironment co-operation may occur in human cancers.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. Δ5.2 removed the ATG start site and 2/3 of the coding region. Genomic rescue stocks were created using BACs from the P[acman] resources, covering the atg13 (CH322-168O18, 21 kbp) or atg14 (CH322-175F03 20 kbp) locus, respectively. Φ C31 integrase-mediated transgenesis was used for site-directed integration in the cytological site 22A3 (Best Gene), creating the g-atg13 and g-atg14 genomic rescue transgenes. Generation of transgenic ey3.5-Hsp70-Atg13. The vector backbone was obtained by cutting pattB with HpaI and XbaI. This PhiC31 integrase-compatible plasmid utilizes the hsp70 minimal promoter to clone the enhancer region; in this case, an eye-specific 'ey3.5' fragment (ey3.5-hsp70P from pEy3.5-tTA plasmid 13 and Atg13 from pBluescript-SK-Atg13 plasmid (LD09558, DGRC)). Fragments were PCR amplified and sub-cloned into the pattB vector using Gibson Assembly Master Mix (E2611L, NEB). For eGFP-Atg13 rescue fly lines, eGFP coding sequence was inserted into pBluescript-SK-Atg13. The resulting Atg13-eGFP fragment was used to generate the pattB-ey3.5-hsp70P-Atg13-eGFP construct (further cloning details are available upon request). X-chromosome-specific insertions of pattB-ey3.5-hsp70P-Atg13 and pattB-ey3.5-hsp70P-Atg13-eGFP were generated with site-directed integration by Φ C31 integrase-mediated transgenesis in the cytological site 2A3 (Best Gene). Immunofluorescence microscopy. Third instar eye-antennal discs were dissected in PBS and fixed in 4% pFA for 30 min at room temperature. Samples were washed twice with PBX (0.3% (v/v) Triton X-100, 3% BSA in PBS) and blocked for 1 h at room temperature. Incubation with the primary antibody was performed overnight at 4 °C, followed by two washes in PBX and incubation with secondary antibody for 2.5 h at room temperature. Hoechst 33342 (Life technologies, H3570, final concentration 5 μ g ml −1 ) and Alexa Fluor-647 Phalloidin (H3572, 1:200) were added to stain nuclei and actin, respectively. For systemic autophagy scoring, mid-L3 larvae (5 days after 24 h egg lay) were dissected and fixed in 4% paraformaldehyde for 5 h, followed by Hoechst and phalloidin staining. Samples were mounted in Vectashield mounting medium (H-1000) and observed with a Zeiss LSM 710 or LSM 780 confocal microscope. Antibodies used in this study: phospho-histone 3 (Upstate, rabbit, 1:1,000), cleaved caspase-3 (Cell Signaling, rabbit, 1:1,000), Ref(2)P (rabbit, 1:2,000), GFP (Invitrogen, rabbit, 1:300), ATPa5 (15H4C4) (Abcam, mouse, 1:1,000). Secondary antibodies were from Jackson Immunoresearch (Alexa Fluor 488, Alexa Fluor 647 and Dy 649) and Molecular Probes (Alexa Fluor 555). EdU incorporation. Cephalic complexes including EADs of wandering L3 larvae were dissected in Schneider's medium (Gibco) and allowed to incorporate EdU (5-ethynyl-2′-deoxyuridine; 5 μ M) for 10 min at room temperature followed by fixation in 4% pFA for 30 min. Samples were washed and blocked in PBX, EdUclick-iT labelling was carried out according to the manufacturer's instructions (Life Technologies, C-10338). Clones were labelled with anti-GFP antibody overnight. 2-NBDG sugar-uptake assay. EADs of third instar larvae were dissected out and collected in Drosophila larval saline (HEPES-NaOH (pH 7.1), 87 mM NaCl, 40 mM KCl, 8 mM CaCl 2 , 50 mM sucrose and 5 mM trehalose) on ice. Discs were incubated at room temperature in 0.25 mM 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)2-deoxyglucose (2-NBDG, Life Lechnologies) for 15 min, rinsed with larval saline, mounted and imaged immediately. Dihydroethidium staining. Dihydroethidium (DHE) staining was performed as described previously (http://www.nature.com/protocolexchange/protocols/414). In brief, EADs of wandering L3 larvae were dissected in Schneider's medium (Gibco) and incubated for 7 min in 30 μ M DHE (Life Technologies, D11347) at room temperature followed by three 5-min washes in Schneider's medium. Discs were subsequently fixed in 4% paraformaldehyde for 5 min, washed once in PBS, mounted and imaged immediately. Tumour volume analysis, pH3 quantification and relative intensity measurements. Cephalic complexes, including EAD, brain lobes and ventral nerve cord, were dissected at day 6, 8 or 10 after 24-h egg lay, fixed in 4% paraformaldehyde and scored for invasion. Representative overview images were taken on a Leica MZ FLIII fluorescence stereomicroscope with a Leica DFC420 camera. Subsequently, samples were mounted in Vectashield for volume quantification with spacers to avoid squashing of the tissue. Confocal z-stacks were recorded with a section thickness of 3 μ m. GFP-positive tumour volume was calculated from 3D-reconstructions of absolute intensities of confocal z-stacks using Imaris 7.6.3 software. Relative clone size was calculated as a ratio of GFP positive tissue volume normalized to total disc volume visualized with Hoechst 33342 staining.
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METHODS
Phosphorylated histone 3 was quantified from single confocal sections. Background was subtracted (rolling ball radius 15 pixels) and phosphorylated histone 3 spots were thresholded automatically using the 'default' threshold in Fiji. Particles smaller than 10 pixels were excluded from analysis. GFP clone area was extracted using rolling ball background subtraction (radius 300 pixels) and 'Li' thresholding. Phosphorylated histone 3 spots within GFP clones were extracted with the binary feature extractor. The area of the full disc was derived from DNA staining with Hoechst. Images were subjected to background subtraction (rolling ball radius 500 pixels) and thresholded with the 'Li' threshold. Phosphorylated histone 3-positive spots within GFP clones were normalized to total numbers of spots and to percentage of GFP-positive tissue area within a disc.
Relative ChAtg8a intensities ratios were calculated by measuring average intensities in 5 ROIs (70-pixel diameter) within and 5 ROIs outside a clone in single confocal sections. Two clones per disc were measured, avoiding the area posterior to the morphogenetic furrow because of the developmental autophagy pattern in this region. Western blotting. Western blotting was carried out according to standard procedures. In total, 20 eye discs or 15-20 ovaries per gel lane were collected on ice in PBS and EDTA-free protease inhibitor cocktail (Roche) and spun down briefly and gently. Supernatant was discarded and pellets were resuspended in 1× Laemmli sample buffer (1-1.5 μ l per eye disc or ovary). Samples were separated on 4-20% mini-PROTEAN TGX gels (Biorad). Primary antibodies used were mCherry (Acris, goat, 1:500), β -actin (Sigma, mouse, 1:5,000) and GAPDH (Abcam, mouse, 1:1,000) followed by horseradish-peroxidase-conjugated secondary antibodies (Jackson Immunolabs). Densitometry measurements were carried out in Fiji. Drug treatment. Drugs were added to standard fly food in the following final concentrations: chloroquine (C6628, Sigma) 2.5 mg ml −1 , SAR405 15 μ M (synthesized by ApexBio). Crosses were flipped directly onto the drug-containing medium. Adult female hosts were kept on a yeast-fortified drug-enriched diet before injection. Yeast was omitted after injection and vials were flipped daily. Allograft assays. Transplantation assays were carried out as previously described 24 .
In brief, young female hosts were kept on a yeast-fortified diet for 2 days before injection. Eight-day-old donor larvae were washed once in ethanol and four times in Millipore water, then tumours were dissected out in PBS. EAD tumour or control tissue were cut into small pieces with a scalpel, aspirated into a sharpened glass capillary and injected into the abdomens of hosts (Nanoject II, Drummond). Vials were flipped daily. Tumours were dissected out 8-10 days after injection and subjected to volume quantification by confocal microscopy. Electron microscopy. For correlative light and electron microscopy experiments, EADs were dissected in PBS and fixed for 1 h on ice in 4% formaldehyde, 0.1% glutaraldehyde/0.1 M PHEM (240 mM PIPES, 100 mM HEPES, 8 mM MgCl 2 , 40 mM EGTA; pH 6.9). Chemically fixed eye imaginal discs were then embedded in 2% (w/v) low-melting-point (LMP) agarose as described previously for C. elegans embryos. A piece of aclar foil was topped with a second piece of aclar foil with a 1 cm × 1 cm hole in the middle. A small drop of pre-warmed LMP LETTER RESEARCH agarose was placed in the middle of this hole. Imaginal eye discs were transferred to the LMP agarose and the cavity was covered with a third piece of aclar foil and a glass slide and everything was put on ice. After agarose gelling the assembly was dismounted and a small piece of agar containing the EAD was punched out using a biopsy punch and transferred to a high pressure freezing carrier. Samples were high pressure frozen using a Leica HPM100, and freeze substitution and embedding were performed as follows: sample carriers designed for flat embedding were filled with 4 ml of freeze substituent (0.1% (w/v) uranyl acetate in acetone) and placed in a temperature-controlled AFS2 (Leica) equipped with an FPS robot (Leica). Freeze-substitution occurred at − 90 °C for 48 h before the temperature was raised to − 45 °C over a time span of 9 h. The samples were kept in the freeze substituent at − 45 °C for 5 h before washing three times with acetone and infiltrated with increasing concentrations of Lowicryl HM20 (10%, 25%, 75%; 4 h each). During the last two steps, the temperature was gradually raised to − 25 °C before infiltration three times with 100% Lowicryl (10 h each). Subsequent UV-polymerization occurred for 48 h at − 25 °C, for 9 h during which the temperature was evenly raised to + 20 °C. Polymerization then continued for another 24 h at 20 °C. Serial sections (~ 100 nm) were cut on an Ultracut UCT ultramicrotome (Leica) and collected on 200-mesh carbon-coated grids. Samples were immediately placed in a water droplet in a glass bottom Mattek dish and observed on a Delta Vision Deconvolution microscope (Applied Precision, GE Healthcare) using a 63× objective and 2 × 2 binning. In order to restore the GFP signal for identification of MARCM clones, the grid was placed in a droplet of 0.01 M NaOH (pH 12) instead of water and observed on a Delta Vision Deconvolution microscope using a 40× objective and 2 × 2 binning. After recording the fluorescent GFP signal, the grid was thoroughly washed in water before commencing with post-staining for electron microscopy. The position of the fluorescent signal relative to the asymmetric centre of the carbon coated grid was later used to find the same position in the electron microscope. After recording the fluorescent signal, the grid was carefully recovered from the water droplet, poststained for 10 min with 2% uranyl acetate in 70% methanol and for 5 min with lead citrate. Sections were observed at 80 kV in a JEOL-JEM 1230 electron microscope and images were recorded using iTEM software with a Morada camera (Olympus). The fluorescent background signal outlining the tissue was used to align the fluorescent image with the electron microscopy image. The overlay of the fluorescent image with the electron micrograph was done with Photoshop CS4. Flow cytometry. For cell cycle profiling, 30-40 third instar EADs per genotype were dissected in PBS and dissociated in 500 μ l 10× trypsin-EDTA solution (Sigma, T4174) by gentle agitation at room temperature for 2 h. Hoechst 33342 (Life Technologies, H3570) was added after 1 h at a final concentration of 5 μ l ml −1 . Trypsin was inactivated with fetal bovine serum (FBS) (2%), suspended cells were transferred into a 5-ml polystyrene tube with cell strainer cap (Falcon, 352235) and stained with propidium iodide for live-dead cell sorting. For mitotracker and mitoSOX measurements, 50-60 third instar EADs per genotype were dissected in PBS and dissociated in 1 ml of 10× trypsin-EDTA solution by gentle agitation at room temperature for 2 h. Trypsin was inactivated with FBS (2%). The cell suspension was centrifuged at 300g for 5 min at room temperature, and the pellet resuspended in Schneider's medium (Gibco) supplemented with 10% FBS (Sigma, 7524). Samples were either incubated with 5 μ M MitoSOX Red (mitochondrial superoxide indicator, Life Technologies, M36008) or 200 nM MitoTracker Deep Red FM (Life Technologies, M22426) at room temperature for 15 min followed by a wash. DNA content or fluorescence intensity was measured on a BD LSR II flow cytometer (Becton Dickinson) and the data were analysed using FlowJo software (Tree Star Inc.). 10,000 GFP-positive cells were analysed for cell cycle profiling, 50,000 cells for Mitotracker and MitoSOX. Seahorse analysis. Approximately 50-100 third instar EADs per genotype were dissociated in 500 μ l trypsin-EDTA (Sigma, T4174) for 2 h followed by inactivation by FBS (2%). The cell suspension was centrifuged at 300g for 5 min at room temperature, and the pellet resuspended in Schneider's medium (Gibco) supplemented with 10% FBS (Sigma, 7524). Cells were passed through a cell strainer and run through FACS DiVa cell sorter (Becton Dickinson). 30,000, GFP + (tumour) or GFP − (microenvironment) cells per well were sorted into Cell-Tak (Corning) coated 96-well Seahorse plates (Seahorse-bio). Sorting was carried out in Schneider's Drosophila medium (Gibco) that was replaced with Seahorse medium supplemented with 2 mM sodium pyruvate, 11 mM glucose and 2 mM l-glutamine (pH 7.4). Respiration rates were measured using Seahorse XF Cell Mito Stress Test-kit (Seahorse Bio) using a Seahorse XFe96 analyser (Seahorse Bioscience). Statistical analysis and reproducibility. Results are presented as mean ± s.e.m. in scatter plots or bar graphs, which were created in GraphPad Prism 5. Data were log-transformed before analysis if necessary to achieve approximately normal distribution. A P value < 0.05 was considered statistically significant for all datasets. Statistical significance was determined by using one-way ANOVA followed by Dunnett's multiple comparisons test for multiple samples. A one-sample t-test was used for comparisons to point-normalized data; two-tailed, unpaired t-tests were used for pairwise comparisons, Chi-squared test for contingency data. RNAi dp 110DN ) discs. m, Quantification of relative ChAtg8a intensities of indicated genotypes. Data are mean ± s.e.m. of three independent pooled experiments. n = 24 (Ras V12 ctrl), n = 20 (Ras V12 scrib −/− ), n = 9 (ImpL2Ras V12 ctrl), n = 12 (upd3Ras V12 ctrl) or 15 (Ras V12 scrib −/− //stat −/− ) discs. Scale bars, 50 μ m (b-j). * P = 0.0127; ns, not significant by unpaired two-tailed t-test (a). * P ≤ 0.05, * * P ≤ 0.01, * * * P < 0.0001 by one-way ANOVA with Dunnett's correction (k-m).
